Found: 3
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 40–47
Merkureva O.N., Kuznetsov I.N., Babkina I.V., Rogozhin D.V., Sushentsov E.A., Gershtein E.S., Kushlinskii N.E.
Introduction. Angiogenesis regulators are of particular interest as new serum markers in cancer patients, since they reflect the intensity of tumor growth and metastasis. Currently, many works are dedicated to the study of vascular endothelial growth factor (V…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 25–32
Gershtein E.S., Kuzmin Yu.B., Alferov A.A., Korotkova E.A., Tsarapaev P.V., Sokolov N.Yu., Kuznetsov I.N., Vashketova O.I., Kozlova E.M., Yanushevich O.O., Boulytcheva I.V., Stilidi I.S., Kushlinskii N.E.
Background. Low sensitivity of bone tumors to various schemes of standard chemotherapy stimulated the search of new targets for their medicamentous treatment. Among such targets are the so-called “immune checkpoints” promoting the escape of the tumor from the …
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018
Kushlinskii N.E., Chernomaz I.S., Gershtein E.S., Boulytcheva I.V., Aliev M.D., Soloviev Yu.N.
Introduction. The search of molecular markers for early diagnostics, prognosis, and identification of new objects for molecular-targeted therapy of primary bone tumors remains one of the most important tasks despite the significant achievements in the treatmen…